GlassScriptPhysician profile
Kurt Wendell Relation
NPI 1467791947
$109,280.42
in general payments reported to CMS, 2019-2025
27 companies · $98K in 2025
The $98K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,792 · 2020: $140 · 2021: $1,718 · 2022: $1,480 · 2023: $2,992 · 2024: $1,289 · 2025: $98K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $84K · Travel and Lodging: $12K · Food and Beverage: $6,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,775.00 |
| Travel and Lodging | $11,829.26 |
| Food and Beverage | $6,545.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $100,610.99 | 2022-2025 | |
| Arthrex, INC. | $2,429.00 | 2019 | |
| Prodigy Surgical Distribution, INC. | $2,016.06 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $495.59 | 2022-2025 | Nuzyra |
| Horizon Therapeutics Plc | $422.57 | 2019-2023 | Krystexxa |
| Smith+Nephew, INC. | $352.75 | 2019-2025 | Grafix Pl |
| Boston Scientific Corporation | $294.79 | 2023-2025 | General - Pain Management |
| Amgen INC. | $293.13 | 2024-2025 | Krystexxa |
| Bioventus LLC | $292.74 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Organogenesis INC. | $285.63 | 2019-2023 | Puraply |
| Advanced Oxygen Therapy INC. | $279.35 | 2020-2025 | Topical Oxygen Chamber For Extremities |
| Kerecis Limited | $181.33 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Nevro Corp. | $155.23 | 2022 | |
| Trilliant Surgical LLC. | $150.00 | 2025 | Arsenal Ankle |
| Tactile Systems Technology INC | $147.84 | 2024 | Entre Plus, Flexitouch Plus |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $136.72 | 2019-2020 | |
| Melinta Therapeutics, LLC | $128.94 | 2019 | |
| Averitas Pharma INC. | $122.07 | 2023-2025 | Qutenza |
| Stryker Corporation | $111.92 | 2019-2020 | |
| Crossroads Extremity Systems, LLC | $108.77 | 2019 | |
| Paragon 28, INC. | $75.08 | 2019-2024 | Portfolio |
| Zimmer Biomet Holdings, INC. | $47.61 | 2019 | |
| Fidia Pharma USA INC. | $42.88 | 2019-2021 | |
| Convatec INC. | $35.38 | 2023-2025 | |
| Dynasplint Systems INC. | $22.80 | 2025 | Dynasplint |
| Misonix INC | $21.82 | 2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.43 | 2025 | Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kurt Relation listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.